J&J halts a depression program in the shadow of fatal French trial

Damian Garde

In the wake of a disastrous clinical that left one volunteer dead, Johnson & Johnson has voluntarily suspended development of a similar drug until more information comes to light.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS